Hit enter to search or ESC to close
No menu assigned
NeonMind to Present at the Benzinga Global Small Cap Conference
NeonMind Engages KCSA Strategic Communications to Provide Public Relations and Investor Relations Services
NeonMind Announces New Specialty Clinics Division to Deliver Innovative Mental Health Services, Appoints New VP, Corporate Development
NeonMind Developing Music Playlist for Psychedelic Therapy Sessions
NeonMind CEO Robert Tessarolo to Speak at the Psychedelic, Therapeutics, & Drug Development Conference
NeonMind CEO Provides Update on the Progress of its Psilocybin Drug Development Research Plan and Team
NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity
NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity
NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data
©2021 NeonMind Biosciences Inc.
©2020 NeonMind Biosciences Inc.